Basic Tool Has Copious Uses in Development of Vaccines and Protein Therapeutics Epitope mapping, initially a basic-science tool for understanding the 3-D interactions between antigens and antibodies, ...
Characterizing the binding sites of monoclonal antibodies (mAbs) on target antigens, their epitopes, can aid in the discovery and development of new therapeutics, diagnostics, and vaccines. For ...
ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its ...
AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, is pleased to announce today new benchmarking results that validate the ...
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the primary target of many drug discovery efforts and is similarly utilized in each of the approved COVID-19 ...
Monoclonal antibodies are crucial therapeutics due to their high specificity and binding affinity for epitopes (the precise sites where an antibody attaches itself to an antigen, triggering an immune ...
Antibodies are a major component of adaptive immunity against invading pathogens. In this presentation, we will describe an analytical approach to characterize the antigen-specific antibody repertoire ...
In a recent article published in Scientific Reports, researchers performed immunoglobulin (Ig)M and IgG epitope mapping against 487 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
The field of proteomics is poised for a single-molecule revolution – enabling more comprehensive analysis of the proteins in a sample with increased sensitivity, reproducibility, and accessibility.
Epitope mapping was performed using structural analysis to classify antibodies according to their binding sites on the receptor-binding domain (RBD). The neutralization activity of representative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results